Advertisement
Screener

INNOVIVA, INC. (INVA) Net Margin

INNOVIVA, INC. (INVA) Net Margin

  • 2026-06-30: Net Margin -69.75%.
  • 2026-03-31: Net Margin 190.41%.
  • 2025-12-31: Net Margin 143.22%.
  • 2025-09-30: Net Margin 83.40%.

Complete source-backed net margin history.

Available history
2011-03-31 to 2026-06-30
Data captured

Historical Net Margin

DateNet Margin
2026-06-30-69.75%
2026-03-31190.41%
2025-12-31143.22%
2025-09-3083.40%
2025-06-3063.51%
2025-03-31-52.56%
2024-12-3122.15%
2024-09-301.36%
2024-06-30-34.72%
2024-03-3147.14%
2023-12-3171.68%
2023-09-30121.99%
2023-06-301.58%
2023-03-3145.65%
2022-12-31-103.82%
2022-09-30341.00%
2022-06-3019.75%
2022-03-3142.04%
2021-12-3142.39%
2021-09-30104.89%
2021-06-30109.96%
2021-03-31128.27%
2020-12-3182.91%
2020-09-3046.93%
2020-06-30124.42%
2020-03-31100.35%
2019-12-3176.16%
2019-09-3071.56%
2019-06-3071.85%
2019-03-3172.52%
2018-12-31337.12%
2018-09-3081.33%
2018-06-3084.39%
2018-03-3157.90%
2017-12-3184.17%
2017-09-3048.86%
2017-06-3060.02%
2017-03-3141.60%
2016-12-3158.40%
2016-03-3118.34%
2015-03-31-154.68%
2012-03-3166.56%
2011-06-30-392.00%
2011-03-31-358.03%

Annual Net Margin

DateNet Margin
2025-12-3165.92%
2024-12-316.52%
2023-12-3157.89%
2022-12-3166.48%
2021-12-3194.12%
2020-12-3187.24%
2019-12-3173.17%
2018-12-31155.68%
2017-12-3161.81%
2016-12-3144.57%
2015-12-31-34.77%

Similar stocks

Stock NameCountryMarket CapPE Ratio
ArriVent BioPharma, Inc. (AVBP)United States$1.485B-10.25
Ultragenyx Pharmaceutical Inc. (RARE)United States$1.456B-5.62
OMEROS CORP (OMER)United States$1.456B5.50
ANAPTYSBIO, INC (ANAB)United States$1.546B-60.20
Kailera Therapeutics, Inc. (KLRA)United States$1.552B
Syndax Pharmaceuticals Inc (SNDX)United States$1.606B-8.82
Oric Pharmaceuticals, Inc. (ORIC)United States$1.367B-8.00
Rapport Therapeutics, Inc. (RAPP)United States$1.623B-14.56
Stoke Therapeutics, Inc. (STOK)United States$1.630B-9.82
Xeris Biopharma Holdings, Inc. (XERS)United States$1.632B-80.10